As the market struggles, it’s a great time to look for undervalued stocks to buy.
There are bargains to be found in the stock market for investors who have nerves of steel and can stomach its volatility. The broad-based decline of equities means that some of the best-run and most dominant companies in the U.S. have undervalued stocks to buy. These names are trading at a huge discount relative to their current and future earnings.
The share prices of many highly profitable, market-leading companies have sunk by 50% or more during the current rout, in many cases erasing the gains that they achieved during the pandemic.
This presents a huge buying opportunity for investors looking to put capital to work in a weak market. And while we may not have achieved a bottom just yet, there are plenty of undervalued stocks to buy at fire-sale prices.
These stocks should pay off handsomely once the market does bottom and share prices permanently reverse higher.
Here are seven of the most undervalued stocks to buy now.
|AMD||Advanced Micro Devices||$64.30|
Undervalued Blue-Chip Stocks to Buy: Alphabet (GOOG, GOOGL)
Following the Google parent company’s most recent earnings report, GOOGL stock dropped 6% making it easily one of the best undervalued stocks to buy.
YouTube’s ad revenue fell 2% year-over-year in the third quarter of 2022, while analysts, on average, were expecting an increase of 3%. Alphabet announced several cost-cutting measures, canceling the next generation of its Pixelbook laptop computer and announcing plans to close Stadia, its digital gaming service. The company also said that it is likely to reduce its workforce in the coming months.
The added pressure on GOOGL stock following the Q3 earnings has dragged the shares down a total of 39% in the past 2 months. (A 20-for-1 stock split in July also lowered the share price). While discouraging, the decline makes Alphabet stock look very attractive at its current levels.
The company’s price-earnings (P/E) ratio has dropped along with the share price to an attractive level of 17 times, which is below the large-cap technology stocks’ average of 25 times.
This year’s pullback is one of the steepest in the company’s history. Investors should take advantage of this rare opportunity.
Home Depot (HD)
Down 23% over the past year, Home Depot (NYSE:HD) recently was at its lowest level since before Covid, making it one of the undervalued stocks to buy before a comeback.
The decline of the retailer’s share price hardly seems justified, considering that the Atlanta-based company reported solid third-quarter earnings.
Home Depot continues to manage inflationary pressures. The company has been focused on serving professional home builders and contractors rather than putting its efforts toward serving do-it-yourself renovators and weekend warriors.
The company’s sales to professionals continue to exceed its revenue from do-it-yourself projects. The firm’s strong Q3 earnings show that Home Depot has been unfairly dragged lower by the market’s downturn.
Add in a P/E ratio on HD stock of 19 and a quarterly dividend that yields 2.41%, and it’s easy to make the case that investors should buy HD stock on the dip.
Advanced Micro Devices (AMD)
In mid-October, investors could purchase the shares of AMD for $55 each, around the same level at which the stock was trading in May 2020. While AMD doesn’t pay a dividend, the company’s earnings have continued to be stellar, and its outlook is strong despite its ongoing challenges caused by supply-chain issues and inflationary pressures.
On Nov. 1, the company reported third-quarter results that fell short of Wall Street analysts’ average expectations. However, the company still posted revenue growth of nearly 30% for the July through September period.
AMD’s latest earnings were also negatively impacted by charges stemming from its $49 billion acquisition of Xilinx in February 2022. Xilinx makes specialty microchips called “field-programmable gate arrays.” Despite its short-term challenges and one-time charges, AMD remains a top semiconductor stock that investors should buy while it’s on sale.
Boeing Company (NYSE:BA) stock was down for the count before last year’s market downturn.
Several high-profile crashes of its aircraft in the last few years had created a crisis of confidence in the Virginia-based manufacturer of passenger airplanes. However, all indications are that Boeing has turned the page and is moving forward with more stringent safety guidelines.
However, this fact hasn’t helped keep BA stock off the list of undervalued stocks to buy. The stock has fallen nearly 10% in the last 12 months.
Investors willing to be patient with BA stock should consider the fact that Boeing is part of a duopoly when it comes to aircraft manufacturing. That’s because France’s Airbus SE (OTC:EADSY) is the only other reputable company in the world that manufactures a high number of commercial passenger airplanes.
This gives Boeing an enormous advantage and puts the company in a strong competitive position. While investors continue to fret about the Federal Aviation Administration (FAA) looking over the shoulders of Boeing’s executives and engineers, they miss the fact that the company continues to win lucrative contracts around the world as airlines move to replace their aircraft fleets.
In late 2020, the company’s Covid-19 vaccine hit the market. Pfizer sold $36.7 billion worth of Covid-19 vaccines globally in 2021, representing 45% of its total revenue. In 2022, the company forecast Covid-19 vaccine sales of $54.5 billion, including booster shots.
Despite the successful addition of its Covid-19 vaccine and the multi-billion dollars of revenue that it has brought in, PFE stock has declined 10% during the past year. The company’s price-earnings ratio is a modest 9.87, suggesting the stock is cheap at its current levels.
Investors who snap up the shares will also benefit from a quarterly dividend that yields 3.20%. Meanwhile, Pfizer is continuing to develop its Covid-19 pill called “Paxlovid,” and some analysts say the pill could be Pfizer’s next blockbuster medication if it gets approved by the FDA.
JPMorgan Chase (JPM)
JPMorgan Chase (NYSE:JPM) is the biggest lender in America with nearly $4 trillion of assets under management, and the largest bank in the world with a market capitalization of $393 billion. It is also one of the better undervalued stocks to buy in the banking sector.
JPMorgan Chase’s Q3 earnings did not disappoint investors. Its earnings serve as a bellwether for the banking industry, and the results bolstered sentiment among investors.
While JPMorgan’s investment banking and equity trading units slowed in Q3, the bank offset those declines with greater income generated from higher interest rates charged on its loans, and also through a bump in its revenue from bond trading.
JPM stock is currently down about 16% in the last year year. However, the bank’s share price has gained 26% in the past three months. The shares also currently have a low price-earnings ratio of 11.5 and pay a quarterly dividend that yields 2.9%.
Undervalued Blue-Chip Stocks to Buy: Target (TGT)
Target (NYSE:TGT) stock has dropped 36% in the last year, making it one of the most undervalued stocks in retail.
The shares of the big-box department store chain had been holding up fairly well until April. That’s when the company reported Q1 earnings that showed that inflation had affected its bottom line and that it had excessive inventory.
While Target has made progress in unwinding its inventories, the company continues to struggle with a host of issues. In mid-November, Target reported a Q3 earnings miss, warned of soft holiday sales, and trimmed its Q4 guidance.
As one might expect, the Q3 print didn’t go over well with analysts or investors. Target cited inflationary pressures that are forcing consumers to prioritize spending as the reason for the poor financial results and difficult outlook. Target also announced plans to cut $3 billion of costs by 2025
On the date of publication, Joel Baglole held a long position in GOOGL. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.